Mayne Pharma: Astrix™ Capsules & Tablets

By: Mayne Pharma (cda)  09-12-2011
Keywords: tablets, Benefits Scheme, Pharmaceutical Benefits Scheme,

Astrix aspirin capsules are the only enteric coated pelletised form of low-dose aspirin on the market, and are used for the same indication as Astrix™ tablets. Their enteric coat allows the release of aspirin to be delayed, until the pellets reach the small intestine, thereby reducing the risk of gastric ulceration that may be experienced with longer term use of immediate release aspirin.

Astrix™ capsules and/or tablets are currently licensed and sold in Australia, Hong Kong, Korea, Mauritius, Singapore and Sri Lanka. Opportunities remain for licensing in a significant number of international territories.

Astrix aspirin tablets are an immediate release low-dose form of aspirin indicated for inhibition of platelet aggregation to help prevent heart attack and stroke in patients with known cardiovascular and cerebrovascular disease.

Mayne Pharma offers Astrix™ capsules and tablets on the Pharmaceutical Benefits Scheme (PBS) in Australia.

Your doctor will advise you whether using Astrix™ capsules or tablets as part of an overall program to manage the risk of heart attack or stroke is suitable for you. Always read the label. Use only as directed. If symptoms persist see your doctor.

Further Information

Keywords: Benefits Scheme, Pharmaceutical Benefits Scheme, tablets,

Contact Mayne Pharma (cda)

Email

Print this page

Other products and services from Mayne Pharma (cda)

09-12-2011

Mayne Pharma: Eryc™ / Erymax™ Capsules

Indicated for the treatment of a wide variety of bacterial infections, Eryc™ erythromycin is formulated to protect erythromycin degrading in the acidic environment of the stomach, for optimal absorption in the intestine. Eryc™ erythromycin capsules are currently licensed and sold in Australia, Canada, Sweden and the United Kingdom. Eryc™ capsules are a delayed release erythromycin produced by Mayne Pharma using proprietary pellet technology.


09-12-2011

Mayne Pharma: Doryx™ Capsules & Tablets

Doryx™ capsules and tablets are delayed release oral formulations of doxycycline, that can be used treat certain types of infections, as adjunctive treatment of severe acne and as an anti-malarial. Doryx™ capsules and tablets contains enteric-coated pellets of doxycycline hyclate and is the only delayed release pelletised doxycycline product on the market.